Caring Brands lines up $11M raise through highly dilutive stock deal

What's the deal? Caring BrandsDealroom has a profile for this one. Try Dealroom → (Nasdaq: CABR) has agreed to raise up to $11 million in gross proceeds through a private placement, the company said. On August 21, 2026, it entered a Securities Purchase Agreement with accredited investors, issuing up to 11,000 shares of newly designated Series B Convertible Preferred Stock at $1,000 apiece, plus warrants for up to 22 million common shares.

The terms: The preferred stock converts to common stock at $0.70 per share and carries an 8% annual dividend, payable in cash or stock. Two tranches of warrants — exercisable at $0.825 and $0.95 — run for five years with full-ratchet anti-dilution protection.

Why now? Closings are happening on a rolling basis, with the final one expected on or before August 28, 2026, subject to conditions. Caring Brands must file a resale registration statement within 30 trading days of closing and secure stockholder approval to exceed Nasdaq's 19.99% exchange cap.

What could go wrong? The deal is highly dilutive: the low conversion price and potential 22 million warrant shares could pile pressure on existing holders. Proceeds are not guaranteed, and failing to keep the registration statement effective triggers monthly damages of 1% of the purchase price, capped at 6%.

Alongside the offering, the company amended its Series A Preferred Stock terms, lifting authorised shares from 4,000 to 4,500 and removing holders' right to demand redemption on a triggering event — easing potential pressure on its cash position.

The signal: At $11 million, the raise sits in the smaller tier of disclosed rounds, ranking in roughly the 34th percentile by amount. For a micro-cap Nasdaq issuer, convertible preferred stock and warrants offer a route to capital that public markets alone won't easily provide — at the cost of steep dilution.

Read more: minichart.com.sg

Image credit: Ken Lund